buthionine sulfoximine has been researched along with Neglected Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comini, MA; Fonseca, MS; Moreira, DS; Murta, SM; Resende, BV; Santi, AM; Zoboli, AP | 1 |
1 other study(ies) available for buthionine sulfoximine and Neglected Diseases
| Article | Year |
|---|---|
Ornithine decarboxylase or gamma-glutamylcysteine synthetase overexpression protects Leishmania (Vianna) guyanensis against antimony.
Topics: Animals; Antimony; Blotting, Western; Buthionine Sulfoximine; Eflornithine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glutamate-Cysteine Ligase; Inhibitory Concentration 50; Leishmania guyanensis; Leishmaniasis, Mucocutaneous; Neglected Diseases; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Rabbits; Recombinant Proteins | 2017 |